Ownership history in PRUDENTIAL FINANCIAL INC · 24 quarters on record
This page tracks every 13F SEC filing in which PRUDENTIAL FINANCIAL INC reported a position in CYTOMX THERAPEUTICS INC (CTMX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 23,300 | -2,400 | -9.3% | 0.00% | $74K | $3.19 |
| 2025 Q2 | REDUCED | 25,700 | -55,800 | -68.5% | 0.00% | $58K | $2.27 |
| 2025 Q1 | ADDED | 81,500 | +17,200 | +26.7% | 0.00% | $52K | $0.64 |
| 2024 Q4 | ADDED | 64,300 | +27,800 | +76.2% | 0.00% | $66K | $1.03 |
| 2024 Q3 | UNCHANGED | 36,500 | — | 0% | 0.00% | $43K | $1.18 |
| 2024 Q2 | ADDED | 36,500 | +4,600 | +14.4% | 0.00% | $45K | $1.22 |
| 2024 Q1 | ADDED | 31,900 | +15,600 | +95.7% | 0.00% | $70K | $2.18 |
| 2023 Q4 | UNCHANGED | 16,300 | — | 0% | 0.00% | $25K | $1.55 |
| 2023 Q3 | REDUCED | 16,300 | -8,400 | -34.0% | 0.00% | $21K | $1.29 |
| 2023 Q2 | REDUCED | 24,700 | -2,400 | -8.9% | 0.00% | $42K | $1.72 |
As of 2025 Q4 — sorted by position size